Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Price:
2.41 USD
-19.93%
Updated:
May 14, 2024
Balance Sheet
Balance Sheet Decomposition
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc
| Current Assets | 6.8m |
| Cash & Short-Term Investments | 6.6m |
| Other Current Assets | 171.7k |
| Non-Current Assets | 684.5k |
| Other Non-Current Assets | 684.5k |
| Current Liabilities | 1m |
| Accounts Payable | 318.7k |
| Accrued Liabilities | 694.9k |
Balance Sheet
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc
Currency: USD
| Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
3
|
20
|
15
|
11
|
|
| Cash |
3
|
20
|
15
|
11
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
2
|
1
|
0
|
|
| Total Current Assets |
3
|
22
|
16
|
12
|
|
| Total Assets |
3
N/A
|
22
+615%
|
16
-28%
|
12
-25%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+9%
|
1
+113%
|
1
+110%
|
|
| Equity | |||||
| Common Stock |
3
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
39
|
45
|
57
|
|
| Additional Paid In Capital |
0
|
60
|
61
|
68
|
|
| Total Equity |
3
N/A
|
21
+665%
|
15
-30%
|
11
-30%
|
|
| Total Liabilities & Equity |
3
N/A
|
22
+615%
|
16
-28%
|
12
-25%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
23
|
23
|
23
|
26
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
